Reaktionsgleichung
[Br:1][C:2]1[N:6]2[CH2:7][CH2:8][CH2:9][N:10]([CH3:12])[CH2:11][C:5]2=[C:4]([C:13](N[C@@H](CC(C)C)C(NC)=O)=[O:14])[N:3]=1.[NH2:25][C@H:26]([C:31]([OH:33])=O)[C:27]([CH3:30])([CH3:29])[CH3:28].[CH3:34][NH:35][CH3:36]>C1COCC1>[Br:1][C:2]1[N:6]2[CH2:7][CH2:8][CH2:9][N:10]([CH3:12])[CH2:11][C:5]2=[C:4]([C:13]([NH:25][C@@H:26]([C:27]([CH3:30])([CH3:29])[CH3:28])[C:31]([N:35]([CH3:36])[CH3:34])=[O:33])=[O:14])[N:3]=1Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
This intermediate was prepared following the synthesis of ((S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-3-bromo-8-methyl-6,7,8,9-tetrahydro-5H-imidazo[1,5-a][1,4]diazepine-1-carboxamide (Intermediate 55B) by replacing Z-Leu-OH with tert-Leu-OH, and replacing methylamine hydrochloride with dimethylamine solution in THF. LCMS (+ESI) m/z 417.1 [M+H]+.
Aufarbeitung
- customThis intermediate was prepared
Quellen und Nachweise
- ORD-Eintrag
- ord-e0de0e797d0d440eb3ff29d772cbc0cb
- Quelldatensatz
- uspto-grants-2014_10
- Patentnummer
- US08859538B2
Verknüpfte Notizen
Wird geladen…